BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9059982)

  • 21. Ryanodine receptor type 1 (RyR1) possessing malignant hyperthermia mutation R615C exhibits heightened sensitivity to dysregulation by non-coplanar 2,2',3,5',6-pentachlorobiphenyl (PCB 95).
    Ta TA; Pessah IN
    Neurotoxicology; 2007 Jul; 28(4):770-9. PubMed ID: 17023049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for intraluminal Ca++ regulatory site defect in sarcoplasmic reticulum from malignant hyperthermia pig muscle.
    Nelson TE; Lin M; Volpe P
    J Pharmacol Exp Ther; 1991 Feb; 256(2):645-9. PubMed ID: 1847206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ca2+ release channels of pigs heterozygous for malignant hyperthermia.
    Shomer NH; Mickelson JR; Louis CF
    Muscle Nerve; 1995 Oct; 18(10):1167-76. PubMed ID: 7659111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Mg(2+) and SR luminal Ca(2+) on caffeine-induced Ca(2+) release in skeletal muscle from humans susceptible to malignant hyperthermia.
    Duke AM; Hopkins PM; Steele DS
    J Physiol; 2002 Oct; 544(Pt 1):85-95. PubMed ID: 12356882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ryanodine receptor in different malignant hyperthermia-susceptible porcine muscles.
    Ervasti JM; Strand MA; Hanson TP; Mickelson JR; Louis CF
    Am J Physiol; 1991 Jan; 260(1 Pt 1):C58-66. PubMed ID: 1824808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of ivermectin and midecamycin on ryanodine receptors and the Ca2+-ATPase in sarcoplasmic reticulum of rabbit and rat skeletal muscle.
    Ahern GP; Junankar PR; Pace SM; Curtis S; Mould JA; Dulhunty AF
    J Physiol; 1999 Jan; 514 ( Pt 2)(Pt 2):313-26. PubMed ID: 9852316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mg2+ dependence of Ca2+ release from the sarcoplasmic reticulum induced by sevoflurane or halothane in skeletal muscle from humans susceptible to malignant hyperthermia.
    Duke AM; Hopkins PM; Halsall PJ; Steele DS
    Br J Anaesth; 2006 Sep; 97(3):320-8. PubMed ID: 16849381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of quercetin on single Ca(2+) release channel behavior of skeletal muscle.
    Lee EH; Meissner G; Kim DH
    Biophys J; 2002 Mar; 82(3):1266-77. PubMed ID: 11867444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complex effects of ryanodine on the sarcoplasmic reticulum Ca2+ levels in smooth muscle cells.
    Gómez-Viquez L; Rueda A; García U; Guerrero-Hernández A
    Cell Calcium; 2005 Aug; 38(2):121-30. PubMed ID: 16055184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of the ryanodine receptor sarcoplasmic reticular Ca2+ channel in skinned fibers of fast- and slow-twitch skeletal muscles from rabbits.
    Su JY; Chang YI
    Pflugers Arch; 1995 Jul; 430(3):358-64. PubMed ID: 7491259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silver ions induce Ca2+ release from the SR in vitro by acting on the Ca2+ release channel and the Ca2+ pump.
    Tupling R; Green H
    J Appl Physiol (1985); 2002 Apr; 92(4):1603-10. PubMed ID: 11896027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancing effect of calmodulin on Ca(2+)-induced Ca2+ release in the sarcoplasmic reticulum of rabbit skeletal muscle fibres.
    Ikemoto T; Iino M; Endo M
    J Physiol; 1995 Sep; 487 ( Pt 3)(Pt 3):573-82. PubMed ID: 8544122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility.
    Lacava C; Michalek-Sauberer A; Kraft B; Sgaragli G; Sipos E; Höller C; Kress HG; Fusi F; Weigl LG
    Pharmacol Res; 2012 Jul; 66(1):80-7. PubMed ID: 22480578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the effects of fluoride on the calcium pumps of cardiac and fast skeletal muscle sarcoplasmic reticulum: evidence for tissue-specific qualitative difference in calcium-induced pump conformation.
    Hawkins C; Xu A; Narayanan N
    Biochim Biophys Acta; 1994 May; 1191(2):231-43. PubMed ID: 8172909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial calcium cycling defect in furazolidone cardiomyopathy.
    O'Brien PJ; Shen H; Weiler JE; Mirsalimi SM; Julian RJ
    Can J Physiol Pharmacol; 1991 Dec; 69(12):1833-40. PubMed ID: 1666332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Divergent effects of ruthenium red and ryanodine on Ca2+/calmodulin-dependent phosphorylation of the Ca2+ release channel (ryanodine receptor) in cardiac sarcoplasmic reticulum.
    Netticadan T; Xu A; Narayanan N
    Arch Biochem Biophys; 1996 Sep; 333(2):368-76. PubMed ID: 8809075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant hyperthermia: a pharmacogenetic disease of Ca++ regulating proteins.
    Nelson TE
    Curr Mol Med; 2002 Jun; 2(4):347-69. PubMed ID: 12108947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclosporin A treatment alters characteristics of Ca2+-release channel in cardiac sarcoplasmic reticulum.
    Park KS; Kim TK; Kim DH
    Am J Physiol; 1999 Mar; 276(3):H865-72. PubMed ID: 10070069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Porcine malignant hyperthermia susceptibility: hypersensitive calcium-release mechanism of skeletal muscle sarcoplasmic reticulum.
    O'Brien PJ
    Can J Vet Res; 1986 Jul; 50(3):318-28. PubMed ID: 3742367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [3H]ryanodine as a probe of changes in the functional state of the Ca(2+)-release channel in malignant hyperthermia.
    Hawkes MJ; Nelson TE; Hamilton SL
    J Biol Chem; 1992 Apr; 267(10):6702-9. PubMed ID: 1313019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.